Antioxidant supplements do not improve male fertility

Antioxidant supplements do not improve semen quality among men with infertility, according to a new study supported by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), part of the National Institutes of Health. The study also found that antioxidant supplements likely do not improve pregnancy and live birth rates.

Antioxidant supplements do not improve male fertility. Photo: R+R Medicinals/Unsplash

Antioxidant supplements are commercially available to help treat male infertility, but research on its effects on semen quality and rates of pregnancy and live birth are limited.

The new study reports on results from the Males, Antioxidants, and Infertility Trial (MOXI), a double-blind, randomized, placebo-controlled clinical study conducted at nine sites across the United States.

The study enrolled 171 couples where the male partner had at least one abnormal reading on an analysis evaluating sperm concentration, mobility, shape and DNA quality; the female partners had normal fertility test results.

Men received a placebo or an antioxidant supplement containing vitamins C, E and D, selenium, l-carnitine, zinc, folic acid and lycopene for at least three months and up to six months.

The study team found no statistically significant differences in sperm concentration, mobility, shape and DNA quality between the placebo and antioxidant groups after three months. Furthermore, live birth rates did not seem to differ at six months between the antioxidant (15%) and placebo (24%) groups.

The authors only had enough participants to evaluate statistical differences in semen quality but not in pregnancy and live birth rates.

According to the authors, MOXI is the largest randomized, placebo-controlled trial to examine the effects of antioxidants, without additional assisted reproductive technology, on male infertility. (National Institutes of Health)

YOU MAY ALSO LIKE

Combined prenatal smoking and drinking greatly increases SIDS risk

Children born to mothers who both drank and smoked beyond the first trimester of pregnancy have a 12-fold increased risk for Sudden Infant Death Syndrome (SIDS) compared to those unexposed or only exposed in the first trimester of pregnancy.

An engineering breakthrough in Type 1 diabetes

A pre-clinical animal study successfully reverse Type 1 diabetes within 24 hours and maintain insulin independence for at least 90 days.

A device helps people with asthma

A small business is developing a device and app to help people monitor chronic lung conditions like asthma, chronic obstructive pulmonary disease, cystic fibrosis, and pulmonary fibrosis when away from the hospital.

Zinc, folic acid supplement does not improve male fertility

Dietary supplements containing zinc and folic acid — marketed as a treatment for male infertility — do not appear to improve pregnancy rates, sperm counts or sperm function, according to a study conducted by the Eunice Kennedy Shriver National Institute of Child Health and Human Development.

Detailed genetic study provides most comprehensive map of risk to date of breast cancer risk

A major international study of the genetics of breast cancer has identified more than 350 DNA ‘errors’ that increase an individual’s risk of developing the disease. The scientists involved say these errors may influence as many as 190 genes.

Obesity Can Affect Kids’ Working Memory

Obese children have a worse working memory than children of normal weight, a new study has found.